Astrazeneca ADR Stock
€69.50
Your prediction
Astrazeneca ADR Stock
Pros and Cons of Astrazeneca ADR in the next few years
Pros
Cons
Performance of Astrazeneca ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Astrazeneca ADR | -0.720% | 2.206% | 15.833% | -10.323% | 8.594% | 2.507% | 46.624% |
GSK plc ADR | -0.580% | 2.381% | 8.861% | -8.995% | 4.878% | 0.000% | -19.532% |
Bayer AG ADR | 5.970% | 9.231% | 1.429% | 1.429% | 43.145% | -46.617% | -48.921% |
Novo Nordisk A/S ADR | 1.880% | 8.482% | -14.587% | -60.648% | -41.866% | -55.207% | -13.982% |
News

Why AstraZeneca Stock Was Topping the Market on Tuesday
AstraZeneca (NASDAQ: AZN) reported an estimates-busting quarter Tuesday morning, and a satisfied market rewarded the company for it. At market close the sturdy pharmaceutical stock had risen by

Why AstraZeneca Stock Got Thumped on Thursday
AstraZeneca (NASDAQ: AZN) might soon be on the hook for an eventual 11-figure payout, and investors weren't all that comfortable with this. A Bloomberg article published Thursday morning said that

Why AstraZeneca Stock Topped the Market on Tuesday
Trading in AstraZeneca's (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly